An immune response ultimately is needed to eliminate the virus, but this research suggests that it’s not the presence of the virus alone that does all the harm to a sick person. Instead, the fluid buildup deep inside the lungs might help kill a person infected with the flu, according to the research, which was conducted in mice.
“My take is that when people die of these illnesses, they’re dying because they can’t breathe,” said Ian Davis, assistant professor of veterinary biosciences at Ohio State University and senior author of the study. “If the lungs aren’t working well, then it doesn’t matter whether a week from now you can make an immune response and clear the virus if you can’t survive that long because you just can’t get oxygen.”
Detailing exactly how flu interferes with fluid clearance in the lungs lays the groundwork for a second phase of related studies to test a new therapy – a drug that is already known to regulate the amount of fluid that builds up in infected lungs.
In the event of a flu pandemic, such a drug, which scientists hope could be inhaled by mouth, might be an important supplement to antiviral medications and ventilators, Davis said.
The research is published in a recent issue of the American Journal of Respiratory and Critical Care Medicine.
Davis and colleagues infected mice with high doses of an influenza A virus to compare oxygen levels and fluid clearance in infected mice to those of healthy mice.
Mice that were infected with the highest doses of flu experienced a steady decline in oxygen in their blood and higher levels of fluid in the lungs. Two days after infection, fluid clearance in these mice was only half as effective as fluid clearance from the lungs of uninfected mice.
Lung infections have been known to cause problems with what is called alveolar fluid clearance, but the effects of the flu on the lungs had not been tested before, Davis said. The alveoli are air spaces deep inside the lungs where oxygen enters the blood in exchange for carbon dioxide to be exhaled.
The scientists used an unusual method to observe the fluid clearance. After being infected, the mice were anesthetized and put on ventilators. The researchers then placed fluid containing protein into one lung of each mouse and tested the fluid 30 minutes later. The amount of protein left in the remaining fluid allowed the investigators to determine whether the infected lung was clearing fluid adequately.
Davis said the study showed that when the flu virus infects cells in the lung, those cells release small molecules, or nucleotides, that are part of the energy-producing and replication machinery of the cell. Those nucleotides then bind to receptors of other cells in a series of events that ultimately shut down the transport of sodium from airways to the blood. All of these interactions take place in the epithelium, the lining of the airways in the lungs.
Under normal conditions, sodium is absorbed from the lungs into the blood and carried away to be excreted by the kidneys. But in infected lungs, when the sodium channels are damaged, more and more fluid builds up in air spaces instead of being pumped across the airway lining and into the blood.
“A little bit of fluid gives us a way to flush the nasties out of the lung,” Davis said. “If you get a bacterial infection and bacteria are all over the lungs and cell surfaces, you release these nucleotides and generate fluid so you can cough up the bacteria and wash them out. The downside is as you build up fluid in the lung, you can’t oxygenate as well.
“If the bacteria or virus wins, you get more and more fluid and you get sicker and sicker. But if you can wash it away, then you’ve won and things go back to normal.”
The potential therapy that Davis is investigating was originally used in earlier research to block the generation of these nucleotides to prove the fluid clearance mechanism behind a different viral lung disease. Now that his newer work has shown that influenza A has the same effect on the lungs, Davis is planning to test the therapy’s effects against flu infection.
The first studies will involve delivering the drug in aerosol form to mice. Davis also plans to culture human epithelial cells to see whether these cells in humans have the same role as do mouse cells in the fluid clearance mechanism.
Davis noted that the current health-care system can help manage most serious cases of the flu, even if some of the sicker patients require ventilation to help them clear fluid and get oxygen to the blood.
“But if we get into a pandemic situation and there are 200 people with low levels of oxygen in their blood and five ventilators, 195 people are out of luck. We hope to develop something that those people can take by aerosol that might reduce the need for that kind of ventilation,” he said.
This work was supported by the National Institutes of Health and Ohio State’s Department of Veterinary Biosciences.
Coauthors of the study are Kendra Wolk, Zachary Traylor and Erin Yu of veterinary biosciences at Ohio State; Eduardo Lazarowski of the Department of Medicine at the University of North Carolina, Chapel Hill; Russell Durbin of the Research Institute at Nationwide Children’s Hospital; and Nancy Jewell and Joan Durbin of the Research Institute at Nationwide Children’s Hospital and Ohio State’s Department of Pediatrics.
Ian Davis | EurekAlert!
Amputees can learn to control a robotic arm with their minds
28.11.2017 | University of Chicago Medical Center
The importance of biodiversity in forests could increase due to climate change
17.11.2017 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig
DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.
Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.
To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...
The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.
Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
15.12.2017 | Trade Fair News
15.12.2017 | Physics and Astronomy
15.12.2017 | Information Technology